- Bloomberg
Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
(Bloomberg) -- Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people with knowledge of the matter said. Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusFor Tenants, AI-Powered Screening Can Be a New Barrier to HousingGTC
- Investing.com HK
亞盛醫藥大漲16% 日本生物製藥公司注資7500萬美元
英偉達還有多少上漲空間？更多分析師目標價，一鍵查看詳情，專屬優惠等你領取！Investing.com -週一（17日），港股三大指數集體低開，盤面上，醫藥板塊漲幅居前，亞盛醫藥-B (HK:6855)大漲16%，沛嘉醫療-B (HK:9996)漲超6%。
